KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the second quarter of 2024. More
Articles
MULN Stock Alert: Mullen Files Federal Spoofing Lawsuit
MULN stock is sinking lower after the company filed a spoofing lawsuit against three financial firms and several John Doe defendants. More
Dear Investors, Welcome to the Long-Awaited Soft Landing
The soft landing of the U.S. economy is here. But there is a small chance that the soft landing could transform into a crash landing. More
Solid as a Rock: 3 Blue-Chip Stocks for a Stable Portfolio
Blue-chip stocks should anchor your portfolio as we tentatively navigate our way into a soft landing economically. More